USANA Health Sciences Announces Fourth Quarter and Full-Year 2010 Financial Results
-- 2010 marks the 8thconsecutive year of record sales ($517.6 million) -- Net sales increase to a quarterly record of $137.5 million -- Earnings per share increase to $2.86 for the year and $0.75 for the quarter -- Guidance provided for 2011
SALT LAKE CITY--(BUSINESS WIRE)-- USANA Health Sciences, Inc. (NASDAQ: USNA) today announced financial results for its fiscal fourth quarter and full-year ended January 1, 2011.
Net sales in the fourth quarter of 2010 increased by 17.8% to a record $137.5 million, compared with $116.8 million in the fourth quarter of the prior year. This growth was due to higher product sales and an increased number of active associates, primarily driven by the Asia Pacific region. Sales from the newly acquired BabyCare operation in China added $4.1 million and favorable changes in currency exchange rates added $3.6 million in sales.
Net earnings in the fourth quarter increased by 21.4% to $12.4 million, or $0.75 per share, compared with $0.66 per share, in the fourth quarter of the prior year. This increase resulted from improved gross profit margins and a lower effective tax rate. Earnings per share gains, however, were partially offset by a higher number of diluted shares outstanding and additional operating costs related to BabyCare operations in China.
For the full-year ended January 1, 2011, net sales increased by 18.5% to a record $517.6 million, compared with $436.9 million in the prior year. This growth was due to higher product sales and an increased number of active associates, primarily driven by the Asia Pacific region. Additionally, favorable changes in currency exchange rates accounted for $21.0 million of the $80.7 million increase.
Net earnings for the full-year 2010 increased by 36.0% to a record $45.7 million, or $2.86 per share, compared with $2.17 per share in the prior year. This increase resulted from improved gross profit margins and a lower effective tax rate, but was partially offset by higher relative operating expenses and a higher average number of diluted shares outstanding.
Net sales in the Asia Pacific region for the fourth quarter of 2010 increased by 39.3% to $78.0 million, compared with the fourth quarter of the prior year. This improvement was primarily due to strong growth in Hong Kong, the Philippines and Japan. In the fourth quarter, the number of active Associates increased by 39.2%, which was primarily the result of growth in Hong Kong, the Philippines, and the addition of 12,000 BabyCare Associates.
"We concluded another record year in Asia Pacific, where more customers and entrepreneurs than ever before benefited from our products and home-based business opportunity," said Chief Executive Officer, Dave Wentz. "While Hong Kong has been the key driver of our growth in Asia Pacific, we anticipate that 2011 will be a transitional year as we turn much of our attention to integrating and growing BabyCare."
During the fourth quarter of 2010, net sales in the North America region decreased by 2.0% to $59.6 million, compared with the fourth quarter of the prior year. The number of Active Associates in the North America region declined by 11.3%, compared with the fourth quarter of the prior year.
"We continue to believe that the North America region is important for the long-term success of USANA." Wentz continued, "In 2011, our primary corporate performance objectives will largely be tied to sales and Associate growth in North America. This, along with the integration and growth of BabyCare, will be our key measures for success in 2011."
Today we are providing initial financial guidance for 2011. We project consolidated net sales to be between $530 million and $550 million and earnings per share to be between $2.85 and $2.95.
Jeff Yates, Chief Financial Officer of USANA, said, "While we aim to continue our momentum during 2011, our initial outlook is cautious as we continue to make the necessary investments to grow our BabyCare business in China. We now expect that the investments required to successfully integrate our companies will be higher than we originally estimated. We believe that an effective transition to BabyCare in China during 2011 is critical to the long-term success of USANA."
USANA will hold a conference call and webcast to discuss this announcement with investors on Wednesday, February 9, 2011 at 11:00AM Eastern Time. Investors may listen to the call by accessing USANA's website at http://www.usanahealthsciences.com.
USANA develops and manufactures high quality nutritional, personal care, and weight management products that are sold directly to Associates and Preferred Customers throughout the United States, Canada, Australia, New Zealand, Hong Kong, Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the Philippines, the Netherlands, and the United Kingdom. Additionally, USANA's wholly-owned subsidiary, BabyCare, Ltd., operates a direct selling business in China. More information on USANA can be found at http://www.usanahealthsciences.com.
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act. Our actual results could differ materially from those projected in these forward-looking statements, which involve a number of risks and uncertainties, including global economic conditions generally, reliance upon our network of independent Associates, the governmental regulation of our products, manufacturing and marketing risks, adverse publicity risks, and risks associated with our international expansion. The contents of this release should be considered in conjunction with the risk factors, warnings, and cautionary statements that are contained in our most recent filings with the Securities and Exchange Commission.
USANA Health Sciences, Inc. Consolidated Statements of Earnings (In thousands, except per share data) (Unaudited) Quarter Ended Year Ended 2-Jan-10 1-Jan-11 2-Jan-10(1) 1-Jan-11 Net sales $ 116,784 $ 137,540 $ 436,940 $ 517,644 Cost of sales 23,567 24,570 89,803 95,482 Gross profit 93,217 112,970 347,137 422,162 Operating expenses Associate incentives 53,353 61,444 196,363 233,187 Selling, general and 24,520 33,401 99,983 120,759 administrative Earnings from operations 15,344 18,125 50,791 68,216 Other income 42 345 187 648 Earnings before income taxes 15,386 18,470 50,978 68,864 Income taxes 5,179 6,079 17,422 23,213 NET EARNINGS $ 10,207 $ 12,391 $ 33,556 $ 45,651 Earnings per share - diluted $ 0.66 $ 0.75 $ 2.17 $ 2.86 Weighted average shares 15,558 16,479 15,432 15,942 outstanding - diluted (1) Derived from audited financial statements USANA Health Sciences, Inc. Consolidated Balance Sheets (In thousands) As of As of 2-Jan-10 1-Jan-11 (Unaudited) ASSETS Current Assets Cash and cash equivalents $ 13,658 $ 24,222 Inventories 25,761 34,078 Other current assets 12,507 21,972 Total current assets 51,926 80,272 Property and equipment, net 57,241 57,568 Goodwill 5,690 16,930 Other assets 8,581 49,032 Total assets $ 123,438 $ 203,802 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities Accounts payable $ 5,810 $ 6,445 Other current liabilities 34,668 51,179 Total current liabilities 40,478 57,624 Line of credit- long term 7,000 - Other long-term liabilities 1,587 1,012 Stockholders' equity 74,373 145,166 Total liabilities and $ 123,438 $ 203,802 stockholders' equity
USANA Health Sciences, Inc. Sales by Region (Unaudited) (In thousands) Quarter Ended 2-Jan-10 1-Jan-11 Region North America United States $ 37,168 31.8% $ 37,067 27.0% Canada 17,631 15.1% 17,059 12.4% Mexico 6,000 5.2% 5,427 3.9% North America Total 60,799 52.1% 59,553 43.3% Asia Pacific Southeast Asia/Pacific 25,502 21.8% 25,080 18.2% Greater China 24,589 21.1% 46,124 33.5% North Asia 5,894 5.0% 6,783 5.0% Asia Pacific Total 55,985 47.9% 77,987 56.7% Consolidated $ 116,784 100.0% $ 137,540 100.0% Active Associates by Region(1) (Unaudited) As of 2-Jan-10 1-Jan-11 Region North America United States 57,000 28.6% 51,000 22.4% Canada 25,000 12.6% 24,000 10.5% Mexico 15,000 7.5% 11,000 4.8% North America Total 97,000 48.7% 86,000 37.7% Asia Pacific Southeast Asia/Pacific 46,000 23.2% 41,000 18.0% Greater China 48,000 24.1% 93,000 40.8% North Asia 8,000 4.0% 8,000 3.5% Asia Pacific Total 102,000 51.3% 142,000 62.3% Total 199,000 100.0% 228,000 100.0% (1) Associates are independent distributors of our products who also purchase our products for their personal use. We only count as active those Associates who have purchased product at any time during the most recent three-month period, either for personal use or for resale. Active Preferred Customers by Region(2) (Unaudited) As of 2-Jan-10 1-Jan-11 Region North America United States 39,000 58.2% 36,000 46.7% Canada 16,000 23.9% 14,000 18.2% Mexico 3,000 4.5% 4,000 5.2% North America Total 58,000 86.6% 54,000 70.1% Asia Pacific Southeast Asia/Pacific 7,000 10.4% 6,000 7.8% Greater China 1,000 1.5% 16,000 20.8% North Asia 1,000 1.5% 1,000 1.3% Asia Pacific Total 9,000 13.4% 23,000 29.9% Total 67,000 100.0% 77,000 100.0% (2) Preferred Customers purchase our products strictly for their personal use and are not permitted to resell or to distribute the products. We only count as active those Preferred Customers who have purchased product at any time during the most recent three-month period.
Source: USANA Health Sciences, Inc.
Released February 8, 2011